| Date | Form | Description | Docs | XBRL | Pages |
| 06/02/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/27/21 | 8-K | Current report filing |
|
9 | |
| 05/04/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/23/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/20/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/09/21 | DEF 14A | Definitive proxy statements |
|
21 | |
| 04/02/21 | 8-K | Current report filing |
|
3 | |
| 03/30/21 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
22 | |
| 03/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conference
Read More...Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant
Read More...Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study
Read More...